Shideh O'Brien

Shideh O’Brien has over 20 years of industry experience, including 10 years in R&D and gene expression. She has worked on all stages of monoclonal antibody development, from pre-clinical to Phase 1-3 trials and regulatory submissions, with a focus on late-stage CMC product development.